University of Nottingham

Korea University College of Medicine hosts seminar inviting Professors Matthew Lambon-Ralph, Dorothee Auer, and Marvin M. Chun to discuss neuroscience advancements, promoting international research collaboration.

Jonathan Dickinson, with extensive biotech and pharma experience, joins Innate Pharma. Previously at Incyte, ARIAD Pharmaceuticals, Bristol-Myers Squibb, and Hoffmann-La Roche, he started at Novartis. Dickinson holds a Bachelor of Science in Genetics and an MBA from the University of Nottingham. Hervé Brailly will advise for a smooth transition and may join the Board.

Genetic defects in carbohydrate digestion influence IBS patients' response to dietary changes, with those carrying defective hCAZyme genes showing significant improvement on a low-FODMAP diet, especially IBS-D patients.

The UK is establishing a £11 million EPSRC-funded HALo hub, led by the University of Liverpool, to become a global leader in long-acting therapeutics (LATs). HALo, involving multiple universities and healthcare trusts, aims to develop new LATs, engage the public, and ensure UK leadership in this healthcare field. LATs, already used in contraception and HIV therapy, promise to revolutionize disease treatment and healthcare management with single-dose administration.

Wellcome Leap’s Quantum for Bio program advances teams to Phase 2, offering up to $750,000 for classical simulations of quantum algorithms in healthcare. Finalists include Infleqtion, University of Nottingham, qBraid Co., University of Copenhagen, Harvard University, Stanford University, Algorithmiq Inc., and University of Cambridge. Phase 3 offers up to $5 million for significant quantum advancements in healthcare.

Research by University of Nottingham identifies genomic traits linked to cholera severity and transmission, using samples from Bangladesh (2015-2021). Findings suggest overlap between genes causing severe and transmissible disease, potentially aiding in developing effective treatments and interventions.

UKRI India and the Government of India have jointly funded £19.4 million for research in farmed animal diseases, understanding geohazards, and sustainable materials. The collaboration includes projects led by UK and Indian researchers, focusing on improving farmed animal health, understanding geohazards, and developing sustainable industrial practices.